Cargando…

No-reflow and platelet reactivity in diabetic patients with ST-segment elevation myocardial infarction: is there a link?

Detalles Bibliográficos
Autores principales:	Kuliczkowski, Wiktor, Miszalski-Jamka, Karol, Kaczmarski, Jacek, Pres, Damian, Gąsior, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770864/ https://www.ncbi.nlm.nih.gov/pubmed/29362576 http://dx.doi.org/10.5114/aic.2017.71615

Ejemplares similares

Left atrial contractile strain is the independent predictor of LV remodeling after ST-segment elevation myocardial infarction
por: Karwat, Krzysztof P, et al.
Publicado: (2015)

Is ST-segment elevation myocardial infarction always a simple diagnosis?
por: Zalas, Krzysztof, et al.
Publicado: (2023)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Conservative treatment of anterior ST-segment elevation myocardial infarction with a large thrombus burden in the left main coronary artery
por: Serafin, Karol, et al.
Publicado: (2022)

Cardiac Magnetic Resonance Shows Improved Outcomes in Patients with an ST-Segment Elevation Myocardial Infarction and a High Thrombus Burden Treated with Adjuvant Aspiration Thrombectomy
por: Zajdel, Wojciech, et al.
Publicado: (2022)

The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction
por: Bolayır, Hasan Ata, et al.
Publicado: (2017)

Platelet‐Lymphocyte ratio is a predictor for the development of no‐reflow phenomenon in patients with ST‐segment elevation myocardial infarction after thrombus aspiration
por: ŞENÖZ, Oktay, et al.
Publicado: (2021)

Predicting coronary no-reflow in patients with acute ST-segment elevation myocardial infarction using Bayesian approaches
por: Zhang, Dongfeng, et al.
Publicado: (2014)

Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention
por: Yaylak, Barış, et al.
Publicado: (2018)

Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020)

Growth Differentiation Factor 15 as a Predictor of the No-Reflow Phenomenon in Patients with ST-Segment Elevation Myocardial Infarction
por: Kożuch, Marcin, et al.
Publicado: (2022)

Predictive value of C-reactive protein/albumin ratio for no-reflow in patients with non-ST-elevation myocardial infarction
por: Rodi Tosu, Aydın, et al.
Publicado: (2022)

Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention
por: Badran, Hala Mahfouz, et al.
Publicado: (2020)

Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Cheng, Chao, et al.
Publicado: (2019)

COVID-19 mimicking ST-elevation myocardial infarction
por: Bujak, Kamil, et al.
Publicado: (2020)

Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Tascanov, Mustafa Begenc, et al.
Publicado: (2019)

Deferment of revascularization in ST-elevation myocardial infarction with coexisting aortic intramural hematoma
por: Błaziak, Mikołaj, et al.
Publicado: (2023)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

Gender-related differences in men and women with ST-segment elevation myocardial infarction and incomplete infarct-related artery flow restoration: a multicenter national registry
por: Zachura, Małgorzata, et al.
Publicado: (2018)

MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study
por: Kuliczkowski, Wiktor, et al.
Publicado: (2017)

Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction
por: Mazhar, Jawad, et al.
Publicado: (2015)

Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
por: Park, Soonyoung, et al.
Publicado: (2013)

Prognostic Association of Circulating Neutrophil Count with No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction following Successful Primary Percutaneous Intervention
por: Tian, Jinfan, et al.
Publicado: (2017)

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018)

Utility of Hematological Parameters in Predicting No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
por: Wang, Zuoyan, et al.
Publicado: (2018)

Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous coronary intervention
por: Deng, Lianxiang, et al.
Publicado: (2022)

A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2021)

RDW as A Predictor for No-Reflow Phenomenon in DM Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Sun, Ying, et al.
Publicado: (2023)

Higher mortality in women after ST-segment elevation myocardial infarction in very young patients
por: Sadowski, Marcin, et al.
Publicado: (2013)

Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronary interventions
por: Zandecki, Łukasz, et al.
Publicado: (2019)

Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Chen, Xinsen, et al.
Publicado: (2020)

Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction
por: Zhou, Shan-Shan, et al.
Publicado: (2015)

Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI
por: Li, Hui, et al.
Publicado: (2018)

Paramedic versus physician-staffed ambulances and prehospital delays in the management of patients with ST-segment elevation myocardial infarction
por: Borowicz, Artur, et al.
Publicado: (2021)

The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients
por: Zhang, Hongyu, et al.
Publicado: (2018)

A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI)
por: Carrick, David, et al.
Publicado: (2014)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
por: Desperak, Piotr, et al.
Publicado: (2020)

Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction
por: Kurdziel, Marta, et al.
Publicado: (2021)

Characteristics and mechanism of reciprocal ST-segment depression in acute ST segment elevation myocardial infarction: Reciprocal ST-segment depression and ST segment elevation myocardial infarction
por: Gao, Qijun, et al.
Publicado: (2022)

LncRNA MALAT1 functions as a biomarker of no-reflow phenomenon in ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention
por: Yang, Xiheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1gosamp3pbtc78ek8l4nf6rkcl